Top Qs
Timeline
Chat
Perspective

5-APB

Empathogenic psychoactive designer drug From Wikipedia, the free encyclopedia

5-APB
Remove ads

5-APB, also known as 5-(2-aminopropyl)benzofuran, is an entactogen of the phenethylamine, amphetamine, and benzofuran families. 5-APB and related drugs have sometimes been informally called "Benzofury".

Quick facts Clinical data, Other names ...

5-APB was first described in the scientific literature in 2000[2][3][4][5] and emerged as a novel designer drug in 2010.[3][4][6][7]

Remove ads

Use and effects

Users describe the effects of 5-APB as including euphoria among others.[3] Largely, its effects reported were similar to those of the drug MDMA but not as strong.[citation needed] The drug has been reported to produce visual disturbances and is said to have mild psychedelic effects.[3][8]

Recreational use of 5-APB has been associated with death in combination with other drugs[9][10] and solely as the result of 5-APB.[11]

Remove ads

Interactions

Pharmacology

Summarize
Perspective

Pharmacodynamics

5-APB acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC50Tooltip half-maximal effective concentration values for monoamine release of 19 nM for serotonin, 21 nM for norepinephrine, and 31 nM for dopamine in rat brain synaptosomes.[6][12] It is also a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI).[6]

5-APB is a potent agonist of the serotonin 5-HT2A and 5-HT2B receptors.[6][12] Its EC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) values were 6,300 nM (54%) at the serotonin 5-HT2A receptor and 280 nM (61–92%) at the serotonin 5-HT2B receptor.[6][12] It also shows affinity for the serotonin 5-HT2C receptor (Ki = 880 nM) and the serotonin 5-HT1A receptor (Ki = 3,300 nM).[6][12] It has been reported to act as an agonist of the serotonin 5-HT2C receptor similarly to the serotonin 5-HT2A and 5-HT2B receptors.[3][13] The drug's potent agonism of the serotonin 5-HT2B receptor makes it likely that 5-APB would be cardiotoxic with long-term use, as seen with other serotonin 5-HT2B receptor agonists such as fenfluramine and MDMA.[citation needed]

5-APB also shows high affinity for the mouse and rat trace amine-associated receptor 1 (TAAR1).[6]

In animal studies, 5-APB produces robust hyperlocomotion, robust conditioned place preference (CPP) but limited self-administration, fully substitutes for MDMA in drug discrimination tests, and partially substitutes for DOM, cocaine, and methamphetamine in drug discrimination tests.[14]

Chemistry

5-APB, also known as 5-(2-aminopropyl)benzofuran, is a phenethylamine, amphetamine, and benzofuran and an analogue of 3,4-methylenedioxyamphetamine (MDA).

Properties

5-APB is commonly found as the succinate and hydrochloride salt. The hydrochloride salt is 10% more potent by mass and doses should be adjusted accordingly.

Synthesis

The chemical synthesis of 5-APB has been described.[5]

Detection

A forensic standard of 5-APB is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[15] The US Department of Justice and DEA have also conducted studies concerning the detection of 5-APB.[16]

Analogues

Analogues of 5-APB include MDA, 5-APDB, 5-MAPB, 6-APB, 5-APBT, and 5-API, among others.

Remove ads

History

5-APB, along with 6-APB, was first described in the scientific literature by Karin Briner and colleagues at Eli Lilly and Company in a patent in 2000.[2][3][4][5] They were specifically studied as serotonin 5-HT2C receptor agonists for potential medical applications at this time.[2][3][4][5] The description of 5-APB and 6-APB in the literature had followed the earlier work on 5-APDB and 6-APDB as serotonin releasing agents and entactogens by David E. Nichols and colleagues at Purdue University in 1993.[4][6][17] 5-APB, along with 6-APB, emerged as a novel designer drug in 2010.[3][4][6][7] 5-APB and 6-APB are often confused with 5-APDB and 6-APDB.[4]

Remove ads

Society and culture

United Kingdom

On March 5, 2014 the UK Home Office announced that 5-APB would be made a class B drug on 10 June 2014 alongside every other benzofuran entactogen and many structurally related drugs.[18]

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads